Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
Q2 2023 vs. Q1 2023
How the institutions holding Adma Biologics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 163 | 179 | +16 |
| Shares | 165.3M | 165.5M | +158.5K (+0.1%) |
| Value | $547.2M | $610.6M | +$63.4M (+11.6%) |
New holders (29)
Institutions that held Adma Biologics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (13)
Institutions that held Adma Biologics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Point72 Asset Management, L.P. | 1,934,576 | $6.40M |
| Marshall Wace, LLP | 114,900 | $380.3K |
| Group One Trading, L.P. | 80,127 | $265.2K |
| Knott David M Jr | 78,143 | $259.0K |
| SG Americas Securities, LLC | 58,507 | $194.0K |
| Maven Securities LTD | 50,000 | $165.5K |
| Beacon Pointe Advisors, LLC | 14,915 | $49.4K |
| Bayesian Capital Management, LP | 11,146 | $36.9K |
| Independent Advisor Alliance | 10,193 | $33.7K |
| Belpointe Asset Management LLC | 2,110 | $6.98K |
| Advisory Services Network, LLC | 500 | $1.66K |
| Ten Capital Wealth Advisors, LLC | 200 | $662 |
| FNY Investment Advisers, LLC | 75 | $0 |